17 studies found for:    Meningitis and Encephalitis
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults
Conditions: Meningococcal Disease;   Meningococcal Meningitis;   Typhoid;   Yellow Fever;   Rabies;   Japanese Encephalitis
Interventions: Biological: Typhoid Vi Polysaccharide Vaccine;   Biological: Yellow Fever Vaccine;   Biological: Japanese Encephalitis Vaccine;   Biological: Rabies Vaccine;   Biological: MenACWY-CRM  Vaccine
2 Terminated
Has Results
Treatment of West Nile Virus With MGAWN1
Conditions: West Nile Neuroinvasive Disease;   West Nile Virus Infection;   Encephalitis;   Meningitis;   Acute Flaccid Paralysis;   West Nile Fever
Interventions: Biological: MGAWN1;   Biological: Placebo - normal saline
3 Completed Nervous System Infections Among Patients With Febrile Seizure
Conditions: Seizure;   Febrile Seizure;   Meningitis;   Encephalitis
Intervention:
4 Terminated IHPOTOTAM : Induced HyPOthermia TO Treat Adult Meningitis
Condition: Bacterial Meningitis
Interventions: Procedure: Mild induced hypothermia (32-34°C);   Procedure: local recommendations and guidelines
5 No longer available Expanded Access to MGAWN1 in Subjects With Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection; or Substantial Accidental Exposure
Condition: West Nile Virus Infection
Intervention: Biological: MGAWN1
6 Completed Side Effects of Bone Marrow Derived CD133 Transplantation in Cerebral Palsy
Condition: Cerebral Palsy
Intervention: Biological: CD133 stem cell injection
7 Terminated An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease
Condition: West Nile Fever
Intervention: Drug: AVI-4020 Injection
8 Recruiting Prevalence of Pathogens in Cerebrospinal Fluid Obtained From Emergency Department Patients
Conditions: Meningoencephalitis;   Other Syndromes Requiring Lumbar Puncture in Emergency Department
Intervention: Other: no intervention
9 Recruiting Singapore Neurologic Infections Program
Condition: Central Nervous System Infections
Intervention:
10 Unknown  Long Term Outcomes of EV71 CNS Infection
Condition: Central Nervous System Infection
Intervention:
11 Completed
Has Results
Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in Adults
Condition: Pneumococcal Infections
Interventions: Biological: 13-valent pneumococcal conjugate vaccine;   Biological: 13vPnC + TIV
12 Completed Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults
Conditions: Pneumococcal Infection;   Influenza
Interventions: Biological: 23-valent pneumococcal polysaccharide vaccine;   Biological: trivalent influenza vaccine;   Biological: 23vPPV+TIV
13 Withdrawn Disc Edema in Patients With Chronic Kidney Disease
Condition: Chronic Kidney Disease
Intervention:
14 Completed Libman-Sacks Endocarditis as a Cause of Neuropsychiatric Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Other: Clinical and laboratory evaluations, transesophageal echocardiography, carotid duplex, transcranial duplex, and magnetic resonance of the brain
15 Active, not recruiting Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus
Condition: Neuropsychiatric Systemic Lupus Erythematosus
Interventions: Procedure: Magnetic Resonance Angiography (MRA);   Procedure: Magnetic resonance imaging;   Procedure: MRA;   Procedure: diffusion Imaging;   Procedure: perfusion imaging.
16 Completed Magnetic Resonance Spectroscopy, Perfusion and Diffusion Tensor Imaging in Neuropsychiatric Lupus
Conditions: Systemic Lupus Erythematosus;   Fibromyalgia;   Acute Neuropsychiatric Lupus
Intervention: Procedure: MRI
17 Not yet recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Intervention: Drug: milatuzumab

Indicates status has not been verified in more than two years